Ascendis Pharma
ASND
ASND
302 hedge funds and large institutions have $13.8B invested in Ascendis Pharma in 2025 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 121 increasing their positions, 91 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 279 → 302 (+23)
0.9% more ownership
Funds ownership: 103.53% → 104.43% (+0.9%)
29% less funds holding in top 10
Funds holding in top 10: 17 → 12 (-5)
Holders
302
Holding in Top 10
12
Calls
$189M
Puts
$60.8M
Top Buyers
| 1 | +$186M | |
| 2 | +$102M | |
| 3 | +$97.3M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$66.1M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
+$48.1M |
Top Sellers
| 1 | -$206M | |
| 2 | -$102M | |
| 3 | -$101M | |
| 4 |
VPC
Vestal Point Capital
New York
|
-$87.8M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$68.5M |
